A Study of Suizenji in Patients With Unresectable Pancreatic Cancer
Clinical trial NCT05601323 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05601323
- Sponsor
- SONIRE Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2027-05-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.